4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Myocardial interstitial fibrosis contributes to left ventricular dysfunction leading to the
development of heart failure. Basic research has provided abundant evidence for the …

The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Ventricular electrical storm (VES) is a clinical scenario characterized by the clustering of
multiple episodes of sustained ventricular arrhythmias (VA) over a short duration. Patients …

Electrical storm is present when a cluster of ventricular arrhythmias (VAs) occurs within a
short time frame. The most widely accepted definition is 3 or more episodes of VA within a …

This virtual workshop was convened by the National Heart, Lung, and Blood Institute, in
partnership with the Office of Strategic Coordination of the Office of the National Institutes of …

Cardiac electrical storm (ES) is characterised by three or more discrete episodes of
ventricular arrhythmia within 24 hours, or incessant ventricular arrhythmia for more than 12 …

Drug safety initiatives have endorsed human iPSC-derived cardiomyocytes (hiPSC-CMs) as
an in vitro model for predicting drug-induced cardiac arrhythmia. However, the extent to …

Electrical storm, characterized by repetitive ventricular tachycardia/ventricular fibrillation
over a short period, is becoming more common with widespread use of implantable …

Electrical storm (ES) is a predictor of mortality, and its treatment is challenging. Moreover,
not all potential therapeutic strategies are available in all hospitals, and a standardized …